Abstract
We report here the clinical experience and management guidelines for the nine consecutive cases who received either an isolated small intestinal graft (n = 1) or an intestine liver combination at the University of Pittsburgh, with FK 506 being the basic immunosuppressive drug therapy.
Publication types
-
Research Support, U.S. Gov't, Non-P.H.S.
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Adult
-
Child
-
Female
-
Gastrointestinal Motility
-
Graft Rejection
-
Humans
-
Intestine, Small / physiology
-
Intestine, Small / transplantation*
-
Male
-
Postoperative Complications / therapy
-
Tacrolimus / therapeutic use
-
Transplantation, Homologous / immunology
-
Transplantation, Homologous / physiology
-
Treatment Outcome